Position in DHR
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,476
-$132,708 QoQ
Shares Held
13
-98.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,059
of 2,092 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026American Capital Advisory, LLC holds $3,124,243 across 16 Diagnostics & Research names. DHR ranks #5 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
11,001 | $3,080,280 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
48 | $24,065 | |
| 3 | ILMN |
Illumina, Inc.
|
22 | $3,868 | |
| 4 | A |
Agilent Technologies, Inc.
|
24 | $3,187 | |
| 5 | DHR |
Danaher Corp /De/
This page
|
13 | $2,476 | |
| 6 | WAT |
Waters Corp /De/
|
5 | $1,875 | |
| 7 | NTRA |
Natera, Inc.
|
5 | $1,357 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
7 | $1,352 |
All Filings in DHR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,476 | 13 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $135,184 | 713 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $164,364 | 718 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $141,161 | 712 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $140,450 | 711 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $144,730 | 706 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $160,685 | 700 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $194,614 | 700 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $174,895 | 700 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $174,804 | 700 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $161,938 | 700 | Shares | Sole | 2024-04-09 | |
| No filing history on record for this holder in this stock. | ||||||